Back to search results

Telehealth Bridge Visits for Newly Diagnosed Diabetes in the Emergency Department

This study is looking at how to better connect people newly diagnosed with type 2 diabetes in the emergency room to ongoing care. It's testing if "Telehealth Bridge Visits" – virtual appointments with a doctor to discuss your new diagnosis, diet, and exercise – can help more people attend their first in-person follow-up appointment compared to standard care. You might be able to join if you are 20-70 years old, live in NYC or Long Island, speak English or Spanish, and were recently diagnosed with diabetes in the emergency room (HbA1c test result of 6.5% or higher). The study aims to enroll 200 participants. The current recruitment status is unclear.

Study design
This study is a randomized controlled trial, meaning participants will be randomly assigned to receive either Telehealth Bridge Visits or standard care. It aims to enroll 200 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will track whether you complete an in-person follow-up outpatient visit for up to 6 months after your diabetes diagnosis.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05899023

ED Diabetes Screening and Outpatient Care - Aim 3

Recruiting
NAAges 20–70InterventionalHealth services
NYU Langone Health
~200 participants
Updated 2026-05-19 on ClinicalTrials.gov
What's tested:Telehealth Bridge VisitsStandard of Care

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit
Measured over Up to Month 6 Post-Diagnosis

Conditions

Diabetes Mellitus
Non Insulin Dependent Diabetes Mellitus

Explore related trials

Diabetes Mellitus

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • David C. Lee · PRINCIPAL_INVESTIGATOR · NYU Langone Health

Who to contact

David C. Lee
[email protected]
212-562-6561
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
Residential address in New York City or Long Island
Primary language is English or Spanish
Able to provide informed consent

Exclusion

No prior history of diabetes
No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)

What this trial measures

  • Percent of Patients who Complete at least One In-Person Follow-up Outpatient VisitUp to Month 6 Post-Diagnosis

    A follow-up outpatient visit excludes the telehealth visits assigned to the experimental group. This outcome will be tracked using phone calls and data from Healthix, a regional health information exchange.